Unknown

Dataset Information

0

EGCG-LYS Fibrils-Mediated CircMAP2K2 Silencing Decreases the Proliferation and Metastasis Ability of Gastric Cancer Cells in Vitro and in Vivo.


ABSTRACT: Aberrant expression of circular RNAs (circRNAs) has been reported to play an important biological regulatory role in gastric cancer (GC). For the purpose of silencing cancer-related genes, a new approach for cancer treatment using nanocarriers to deliver siRNA has been proposed. In this study, abundantly expressed circMAP2K2 (hsa_circRNA_102415) is identified in GC cells. CircMAP2K2 regulates the PCBP1/GPX1 axis through proteasome-mediated degradation, which further mediates the activation of the AKT/GSK3β/epithelial-to-mesenchymal transition (EMT) signaling pathway and enhances the proliferation and metastatic ability of GC cells. To establish novel GC treatment, epigallocatechin-3-gallate-lysozyme (EGCG-LYS) fibrils are synthesized, and in vitro experiments demonstrate that EGCG-LYS has a higher siRNA delivery efficiency than Lipofectamine 2000 (lipo2000), which effectively silences the expression of circMAP2K2. Further studies show that EGCG-LYS carrying siRNA can successfully achieve lysosome escape, which allows it to be located in the cytoplasm to achieve post-transcriptional gene silencing. In addition, EGCG-LYS carrying si-circMAP2K2 has good circulating stability, excellent biosafety and antitumor ability in vivo. The EGCG-LYS fibrils delivery system provides a new tool and approach for the treatment of GC.

SUBMITTER: Dong J 

PROVIDER: S-EPMC10646246 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

EGCG-LYS Fibrils-Mediated CircMAP2K2 Silencing Decreases the Proliferation and Metastasis Ability of Gastric Cancer Cells in Vitro and in Vivo.

Dong Jiaqi J   Zheng Zhousan Z   Zhou Mi M   Wang Yunfei Y   Chen Jiajie J   Cen Junjie J   Cao Tiefeng T   Yang Taowei T   Xu Yi Y   Shu Guannan G   Lu Xuanxuan X   Liang Yanping Y  

Advanced science (Weinheim, Baden-Wurttemberg, Germany) 20230926 32


Aberrant expression of circular RNAs (circRNAs) has been reported to play an important biological regulatory role in gastric cancer (GC). For the purpose of silencing cancer-related genes, a new approach for cancer treatment using nanocarriers to deliver siRNA has been proposed. In this study, abundantly expressed circMAP2K2 (hsa_circRNA_102415) is identified in GC cells. CircMAP2K2 regulates the PCBP1/GPX1 axis through proteasome-mediated degradation, which further mediates the activation of th  ...[more]

Similar Datasets

| S-EPMC7327138 | biostudies-literature
| S-EPMC3870526 | biostudies-literature
| S-EPMC10162881 | biostudies-literature
| S-EPMC6240561 | biostudies-literature
| S-EPMC7942994 | biostudies-literature
| S-EPMC6174816 | biostudies-literature
| S-EPMC3157577 | biostudies-literature
| S-EPMC2867908 | biostudies-literature
| S-EPMC3674815 | biostudies-literature
| S-EPMC9045245 | biostudies-literature